CAll; Cytokines Allergy and Cancer

Description of the granted funding

The study investigates soluble inflammatory mediators, cytokines in initiation and maintenance of inflammation. Precise understanding of how cytokines work, yields in better diagnostics and more specific treatments for diseases where cytokine function is impaired, including allergy and autoimmune diseases. To gain broad physiological understanding on how cytokines work, the study is carried out mainly in experimental rodent models (mouse). The study is mainly done at Tampere University, while certain parts of the work are done in close collaboration with the US National Institute of Health (NIH) (student exchange, scientific cooperation, method exchange). Further information of the study: https://www.tuni.fi/en/research/cytokine-biology Publications: doi: 10.1093/jleuko/qiad065 doi: 10.1016/j.jid.2021.11.013 doi: 10.4049/jimmunol.1600753 doi: 10.1186/s12865-023-00565-0
Show more

Starting year

2025

End year

2029

Granted funding

Ilkka Junttila Orcid -palvelun logo
243 582 €

Funder

Research Council of Finland

Funding instrument

Clinical researcher

Decision maker

Scientific Council for Biosciences, Health and the Environment
16.06.2025

Other information

Funding decision number

369146

Fields of science

Biomedicine

Research fields

Biolääketieteet

Identified topics

pharmacy, biomedicine